Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,371.45
+22.80 (1.69%)
At close: Sep 16, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 165.43 billion as of September 16, 2026. Its market cap has increased by 44.90% in one year.
Market Cap
165.43B
Enterprise Value
158.17B
Revenue
25.90B
Ranking
n/a
PE Ratio
27.43
Stock Price
1,371.45
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 165.43B, an increase of 80.38%. That is a compound annual growth rate of 12.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 165.43B | 47.11% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 288.97B |
| Shilpa Medicare | 178.34B |
| Suven Life Sciences | 88.03B |
| Symbiotec Pharmalab | 69.40B |
| Gujarat Themis Biosyn | 55.76B |
| IOL Chemicals and Pharmaceuticals | 52.67B |
| NGL Fine-Chem | 15.83B |
| Bajaj HealthCare | 10.78B |